Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion type Assertion NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_head.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion description "[In conclusion, our study has revealed a new mode of PI3K alteration in primary endometrial tumors and warrants future studies to determine whether PIK3R1 mutations correlate with clinical outcome to targeted therapies directed against the PI3K pathway in EEC and NEEC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_provenance.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion evidence source_evidence_literature NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_provenance.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion SIO_000772 21478295 NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_provenance.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion wasDerivedFrom befree-20150227 NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_provenance.
- NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_assertion wasGeneratedBy ECO_0000203 NP624503.RAvvknMxl9xDFB6_SMpK3M7nX173TD08fUzV2KHsY3dG0130_provenance.